je.st
news
Tag: corp
InvestorsObserver releases comments on Coca-Cola, CVS Corp.,...
2015-02-10 05:20:56| Auto Parts - Topix.net
To see what our analysts have discovered about these stocks read the InvestorsObserver's Stocks To Watch guide at http://www.investorsobserver.com/stw/20620150 . The following stocks are featured in the Stocks To Watch guide: Coca-Cola , CVS Corp. , Occidental Petroleum , Advance Auto Parts , and InvestorsObserver's Stocks To Watch guide provides investors with critical information on stocks that may be poised for a significant move.
Tags: comments
releases
corp
cvs
TSX Delisting Review - Candente Gold Corp.
2015-02-09 16:07:17| Paper - Topix.net
TMX Group's key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, TMX Select, Alpha, The Canadian Depository for Securities, MontrA©al Exchange, Canadian Derivatives Clearing Corporation, NGX, BOX Options Exchange, Shorcan, Shorcan Energy Brokers, Equicom and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, data products and other services to the global financial community.
Bluvision Partners with GTX Corp. to Create the BLE SmartSole Monitoring System
2015-02-09 11:31:46| Industrial Newsroom - All News for Today
Advanced Bluetooth Technology Gives Patients Freedom While Caregivers Keep A Watchful Eye From Their Smartphone FT. LAUDERDALE, Fla., Today, Bluvision (www.Bluvision.com) announces its integration with GTX Corp., a pioneer and global provider of personal location wearable technologies, in developing a smart...
Tags: system
create
partners
monitoring
5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp.
2015-02-09 06:35:48| Semiconductors - Topix.net
According to GuruFocus list of 5-year lows , these Guru stocks have reached their 5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Vivus Reached $2.50 The prices of Vivus shares have declined to $2.50, which is only 3.6% above the 5-year low of $2.41. It is now 92.3% off the 5-year high of $31.21.
Tags: capital
corp
pharmaceuticals
lows
Harris Corp. buying Exelis in deal worth more than $4B
2015-02-08 05:01:07| Telecom - Topix.net
Under a definitive purchase agreement announced Friday, Harris will acquire Exelis in a cash and stock transaction worth about $4.75 billion. "Acquiring Exelis is transformational for Harris," said William M. Brown, chairman, president and chief executive officer of Harris.
Sites : [457] [458] [459] [460] [461] [462] [463] [464] [465] [466] [467] [468] [469] [470] [471] [472] [473] [474] [475] [476] next »